NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT04521686 2025-06-27Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT03434262 2024-05-31SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsSt. Jude Children's Research HospitalPhase 1 Completed68 enrolled
NCT03684811 2023-11-18A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 MutationNovo Nordisk A/SPhase 1/2 Completed93 enrolled 24 charts
NCT03607643 2018-07-31A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesLeaf Vertical Inc.Phase 1/2 Unknown160 enrolled